Edith Cowan University

Research Online
Research outputs 2022 to 2026
8-16-2022

Visually identified Tau 18F-MK6240 PET patterns in symptomatic
Alzheimer's disease
Natasha Krishnadas
Kun Huang
Stephanie A. Schultz
Vincent Doré
Pierrick Bourgeat

See next page for additional authors

Follow this and additional works at: https://ro.ecu.edu.au/ecuworks2022-2026
Part of the Diseases Commons
10.3233/JAD-215558
Krishnadas, N., Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., Goh, A. M., ... & Rowe, C. C. (2022). Visually identified
Tau 18F-MK6240 PET patterns in symptomatic Alzheimer's disease. Journal of Alzheimer's Disease, 88(4),
1627-1637. https://doi.org/10.3233/JAD-215558
This Journal Article is posted at Research Online.
https://ro.ecu.edu.au/ecuworks2022-2026/1296

Authors
Natasha Krishnadas, Kun Huang, Stephanie A. Schultz, Vincent Doré, Pierrick Bourgeat, Anita M. Y. Goh,
Fiona Lamb, Svetlana Bozinovski, Samantha C. Burnham, Joanne S. Robertson, Simon M. Laws, Paul
Maruff, Colin L. Masters, Victor L. Villemagne, and Christopher C. Rowe

This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworks2022-2026/1296

Journal of Alzheimer’s Disease 88 (2022) 1627–1637
DOI 10.3233/JAD-215558
IOS Press

1627

Visually Identified Tau 18F-MK6240 PET
Patterns in Symptomatic Alzheimer’s
Disease
Natasha Krishnadasa,b , Kun Huangb , Stephanie A. Schultzb , Vincent Doréb,c , Pierrick Bourgeatd ,
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Abstract.
Background: In Alzheimer’s disease, heterogeneity has been observed in the postmortem distribution of tau neurofibrillary
tangles. Visualizing the topography of tau in vivo may facilitate clinical trials and clinical practice.
Objective: This study aimed to investigate whether tau distribution patterns that are limited to mesial temporal lobe
(MTL)/limbic regions, and those that spare MTL regions, can be visually identified using 18 F-MK6240, and whether these
patterns are associated with different demographic and cognitive profiles.
Methods: Tau 18 F-MK6240 PET images of 151 amyloid-␤ positive participants with mild cognitive impairment (MCI) and
dementia were visually rated as: tau negative, limbic predominant (LP), MTL-sparing, and Typical by two readers. Groups
were evaluated for differences in age, APOE 4 carriage, hippocampal volumes, and cognition (MMSE, composite memory
and non-memory scores). Voxel-wise contrasts were also performed.
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Results: Visual rating resulted in 59.6% classified as Typical, 17.9% as MTL-sparing, 9.9% LP, and 12.6% as tau negative.
Intra-rater and inter-rater reliability was strong (Cohen’s kappa values of 0.89 and 0.86 respectively). Tracer retention in a
“hook”-like distribution on sagittal sequences was observed in the LP and Typical groups. The visually classified MTL-sparing
group had lower APOE 4 carriage and relatively preserved hippocampal volumes. Higher MTL tau was associated with
greater amnestic cognitive impairment. High cortical tau was associated with greater impairments on non-memory domains
of cognition, and individuals with high cortical tau were more likely to have dementia than MCI.
Conclusion: Tau distribution patterns can be visually identified using 18 F-MK6240 PET and are associated with differences
in APOE 4 carriage, hippocampal volumes, and cognition.
Keywords: Alzheimer’s disease, cognition, 18 F-MK6240, patterns, positron emission tomography, tau

INTRODUCTION
Alzheimer’s disease (AD) is a progressive
neurodegenerative condition characterized by extracellular amyloid-␤ (A␤) plaques, intracellular tau
neurofibrillary tangles (NFT) and neurodegeneration.
In AD, clinical manifestations, patterns of atrophy,
and regional glucose hypometabolism are linked to
the in vivo regional distribution of tau [1–4].
The spatiotemporal distribution of tau has been
considered relatively stereotyped, consistent with the
Braak staging system [5, 6]. This classification system describes six stages of tau deposition, with initial
deposition in trans-entorhinal and entorhinal regions,
extending into limbic regions, with later involvement of association cortices [5]. Postmortem studies
of individuals with AD have identified patterns of
tau distribution that depart from the Braak framework [7, 8]. These include limbic predominant (LP)
and hippocampal sparing (HpSp) subtypes [7, 8]. On
postmortem analysis, the LP subtype has been characterized by a higher burden of tau in limbic regions
with sparing of the cortex, and the HpSp subtype has
been characterized by high cortical tau with relative
sparing of the hippocampus and limbic regions [7].
This heterogeneity in the distribution of tau has been
associated with differences in the presentation of AD,
with these studies reporting that individuals with AD
who have a LP or HpSp subtype on postmortem differ in their age of symptom onset [7, 8], and rate of
cognitive decline [7] relative to individuals with high
tau burden in both the MTL and cortex.
18 F-Flortaucipir has recently become the first tau
PET tracer approved for clinical use in AD [9].
Visualizing the topography of tau in vivo could facilitate clinical trials and clinical practice. A visual
read method for 18 F-Flortaucipir has identified mesial
temporal lobe (MTL) and focal cortical tracer retention patterns associated with AD [10]. However,

choroid plexus off-target binding of 18 F-Flortaucipir
makes interpretation of tracer retention in the hippocampus challenging [11]. Tau tracer 18 F-MK6240
has high affinity for tau NFT in AD [12], has a
two-fold higher dynamic range for mesial temporal
standardized uptake value ratio (SUVR) compared
to 18 F-Flortaucipir [11], and lacks off-target binding
in the choroid plexus above the hippocampus [13].
Thus, we aimed to investigate whether i) tau distribution patterns that are limited to MTL/limbic regions,
or that spare MTL regions, could be visually identified using 18 F-MK6240; and ii) determine whether
these visually classified groups differ in terms of
their demographic characteristics, cognitive profiles
or APOE genotype.
MATERIALS AND METHODS
Participants (primary analysis)
Participants from the Australian Imaging Biomarkers and Lifestyle (AIBL) study of ageing [14] and
the Australian Dementia Network were included if
they completed an A␤ and tau 18 F-MK6240 PET scan
prior to January 2021. Participants were included if
they met the following criteria: 1) ≥50 years of age;
2) A␤ positive (Centiloid >25); 3) were fluent in
English; 4) had completed at least 7 years of education; 5) did not have any history of neurological or
psychiatric disorders, drug or alcohol abuse or dependence, or any other unstable medical condition; and 6)
were given a contemporaneous clinical diagnosis of
mild cognitive impairment (MCI) or AD dementia,
based on their performance on a battery of cognitive assessments that AIBL participants undergo
every 12 to 18 months. A multi-disciplinary clinical
review panel, blinded to A␤ and tau 18 F-MK6240
PET results, determines whether participants meet
criteria for a diagnosis of MCI or AD dementia in
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accordance with international consensus criteria, as
previously described [15]. All relevant institutional
review boards approved this study. Written informed
consent was obtained from all participants.
Neuropsychology assessment
All participants completed the full AIBL neuropsychology assessment battery, as described previously
[14]. In this study, the Mini-Mental State Examination (MMSE) total score was used to assess global
cognition, and composite scores were used to assess
1) memory and 2) non-memory domains of cognition.
The normative sample for neuropsychology assessments used in this study comprised eighty-seven
AIBL participants who were deemed cognitively
unimpaired (CU) by the multi-disciplinary clinical review panel, based on their neuropsychology
assessments [14]. These participants were selected
to comprise the normative sample if they had a
classification of CU at their baseline visit and at 18months follow-up, and were negative for A␤, tau, and
neurodegeneration. This normative sample had the
following characteristics: 1) 46% male; 2) mean age
68.0 ± 3.7; 3) MMSE ≥28, Clinical Dementia Rating
total and sum of boxes = 0; and Geriatric Depression
score <5.
The test scores obtained by participants in the primary analysis were standardized using the means and
standard deviations of the test scores obtained from
the normative sample. These z-scores were averaged
across the tests to generate two cognitive composite
scores. The composite memory score comprised the
participants’ scores from the following tests: the California Verbal Learning Test II (CVLT-II) long delay,
the Rey Complex Figure Test (RCFT) long delay, and
the Logical Memory (LM) long delay. The composite
non-memory score comprised the scores on the following tests: RCFT copy, Boston Naming Test (30
item; BNT), Verbal Fluency (FAS total score), digit
span total, digit symbol (coding) and category fluency
tasks (animals and boys names total score).
APOE genotyping
APOE genotype was determined from whole blood
extracted DNA, as per the previously described
methodology [15], and was available for 122/151
participants. APOE 4 was dichotomized into the
presence (heterozygous, homozygous) or absence (no
copies) of the 4 allele.
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Statistical analysis for demographics and
cognition
To compare demographic characteristics between
groups, one-way between subjects’ analysis of variance (ANOVA) with post-hoc Tukey’s HSD was
performed for continuous variables and chi-square
tests with pair-wise z-tests for categorical variables.
To evaluate the relationship between the visual rating classification and cognitive measures, analysis
of covariance (ANCOVA) was performed, where the
independent variable was the visual rating classification (fixed factor), and the dependent variable was
the cognitive score (MMSE, composite memory or
composite non-memory score), adjusted for age and
A␤ burden (Centiloid).
Image acquisition
Tau PET imaging involved the intravenous administration of 185 MBq (±10%) 18 F-MK6240 with a
20-min acquisition time commencing 90 min postinjection. A␤ PET imaging involved the intravenous
administration of 200 MBq (±10%) 18 F-NAV4694
with a 20-min acquisition commencing 50 min postinjection. PET scans were acquired on one of two
scanners: Philips TF64 PET/CT or a Siemens Biograph mCT. Philips TF64 PET/CT scans (n = 76)
were reconstructed using LOR 3D Ramla algorithm and the smoothing parameter was set as sharp.
Siemens Biograph mCT scans (n = 75) were reconstructed using an OSEM-3D with 4 iterations and 12
subsets. Low dose CT was obtained for attenuation
correction. All participants had a structural 3T MRI
on a Siemens Skyra scanner to obtain high-resolution
T1 weighted anatomical magnetization-prepared
rapid gradient echo (MPRAGE) sequences.
Image analysis
Tau 18 F-MK6240 PET scans were spatially
normalized into MNI space using a CapAIBL PCAbased approach [16] and scaled using the cerebellar
cortex as the reference region (Supplementary Figure 1). A gray matter inclusion mask [17] and a
meninges exclusion mask were applied. To generate the meninges mask, 40 A␤ negative CU AIBL
participants’ 18 F-MK6240 PET scans were visually
assessed for the presence of meninges uptake. Mean
scans for participants with or without uptake in the
meninges (19 versus 21 individuals) were generated,
and the meninges mask was generated as the dif-
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Fig. 1. Examples of the four tau 18 F-MK6240 PET visual classification categories. Representative tau 18 F-MK6240 PET SUVR images for
participants classified as A) tau negative; B) LP predominant; C) MTL-sparing; and D) Typical. The red boxes highlight 18 F-MK6240 tracer
retention in a “hook”-like distribution, observed in the LP and Typical cases, and the relative absence of 18 F-MK6240 tracer retention in
these structures in the MTL-sparing case, where instead tracer retention is observed in the inferior temporal lobe.

ference between these two mean images. A␤ PET
scans were spatially normalized using CapAIBL, and
the CapAIBL approach was applied for quantitation [18]. Centiloid >25 defined a positive scan [19].
T1-weighted MR sequences were used to generate
hippocampal volumes, using a method previously
described [20].
Tau 18 F-MK6240 PET visual classiﬁcation
The visual rating approach to classify the tau 18 FMK6240 scans was established on a set of 30 scans

by two readers (SAS, CCR). There were four visual
classification categories: 1) tau negative (representing
no 18 F-MK6240 retention, or 18 F-MK6240 retention
limited to rhinal and entorhinal regions); 2) limbic
predominant (LP) (representing 18 F-MK6240 tracer
retention in a “hook”-like distribution on sagittal
slices in the mesial temporal lobe (MTL), with or
without extension into the inferior temporal lobe,
and no other cortical retention); 3) mesial temporal lobe sparing (MTL-sparing) (representing cortical
18 F-MK6240 tracer retention, with no or minimal
tracer retention in a “hook”-like distribution in the
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MTL); and Typical (representing both MTL and cortical 18 F-MK6240 tracer retention) (Fig. 1). A third
reader (NK) was trained in this approach. Training
comprised receiving a description of these visual classification categories, and completing a training set of
10 scans that included examples from the four categories (blind to participant characteristics). Further
details about this method are outlined in the Supplementary Material.
The entire set of scans was then independently
rated by two readers (CCR and NK), blind to participant characteristics in MedView (version 12), using
a white-black scale, without MR overlay. A colorscale was not utilized. The expert reader (CCR) was
a Nuclear Medicine Physician with over 4-years of
research experience with 18 F-MK6240 PET imaging, who read the entire set of 18 F-MK6240 scans
18-months after the initial visual rating approach was
established. The second reader (NK) rated the scans
twice (9-months apart), with the second read performed blind to the results from the first read. Cohen’s
kappa statistic was used to calculate intra- and interrater reliability. Where the two readers differed in
their responses, the scans were jointly reviewed, and
consensus classification determined. The consensus
classification was used for all further analyses presented.
Tau 18 F-MK6240 voxel-wise analysis
As all the 18 F-MK6240 images were in the same
standard space, statistical analysis at a voxel-wise
level was performed. T-map images were computed,
corresponding to voxel-wise relative differences
between groups, with a threshold of significance of
p < 0.001 (uncorrected for multiple comparisons).
Tau 18 F-MK6240 region of interest analysis
ROI analysis was performed. This analysis was not
independent to the visual classification, but rather was
performed to compare the quantitative burden of 18 FMK6240 in the MTL and cortex across the visually
classified groups. Standardized uptake value ratios
(SUVR) were generated for three composite ROI:
mesial temporal (Me) (comprising the entorhinal cortex, amygdala, hippocampus and parahippocampal
gyrus), temporoparietal (Te) (comprising the inferior
and middle temporal, fusiform, supramarginal and
angular gyri, posterior cingulate/precuneus, superior
and inferior parietal, and lateral occipital cortices);
and rest of neocortex (R) (comprising the dorsolat-
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eral and ventrolateral prefrontal, orbitofrontal cortex,
gyrus rectus, superior temporal, and anterior cingulate) [21].
RESULTS
Visually classiﬁed groups
Of the 529 AIBL participants who completed an
A␤ and a tau 18 F-MK6240 PET scan prior to January 2021, 151 met inclusion criteria. Participants’
18 F-MK6240 PET scans were visually classified into
four categories: tau negative (12.6%), LP (9.9%),
MTL-sparing (17.9%), and Typical (59.6%) (Fig. 2).
Strong intra-rater reliability was observed for the
second reader, who rated the scans twice over a 9month period (Cohen’s kappa 0.89, CI 0.82–0.96,
p < 0.001). Strong inter-rater reliability was observed
for visual rating classification against the expert
reader (Cohen’s kappa 0.86, CI 0.78–0.93, p < 0.001).
Supplementary Tables 1–4 show the percentage
agreement between the two readers for each visual
classification category.
Characteristics of the visually classiﬁed groups
The LP group had a lower proportion of females;
however, there were no significant differences across
the groups in terms of age (at the time of tau
18 F-MK6240 scanning), sex, or years of education
(Table 1). The MTL-sparing group had a significantly
lower APOE 4 prevalence than the tau negative, LP,
and Typical groups. While all participants were A␤
positive (Centiloid >25), as per the inclusion criteria,
the tau negative group had a significantly lower mean
Centiloid value than the LP, MTL-sparing and Typical
groups. The LP and Typical groups had significantly
smaller hippocampal volumes than the MTL-sparing
group. Participants in the tau negative and LP groups
were more likely to be classified as having MCI than
dementia, while participants in the MTL-sparing and
Typical groups were more likely to be classified as
having dementia than MCI. However, these differences were not statistically significant.
Visually classiﬁed groups and cognition
Two participants (both visually classified as Typical) were outliers based on their low MMSE scores
(MMSE of 3 and 8) and were excluded from further
analyses of cognition. The MTL-sparing group had
significantly lower MMSE scores than the tau negative and LP groups (Fig. 3A). The LP and Typical
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Fig. 2. Tau 18 F-MK6240 mean images for the visually classified groups. Representative transaxial (top row), coronal (middle row), and
sagittal (bottom row) mean tau 18 F-MK6240 PET SUVR images for the visually classified groups A) tau negative; B) limbic predominant
(LP); C) mesial temporal lobe sparing (MTL-sparing); and D) Typical.
Table 1
Cohort demographics and characteristics

Age (y)
Sex, F (%)
Education (y)
APOE 4+ (%)∗
Centiloid†
HV (cm3 )‡
MCI n (%)
Dementia n (%)

Overall
n = 151

Tau negative
n = 19

LP
n = 15

MTL-sparing
n = 27

Typical
n = 90

72.9 (8.0)
72 (47.7)
12.2 (3.0)
85 (56.3)
114.1 (41.6)
2.60 (0.3)
67 (44.4)
84 (55.6)

74.3 (6.4)
10 (52.6)
12.5 (3.3)
11 (57.9)
62.7 (33.3)
2.64 (0.4)
12 (63.2)
7 (36.8)

75.9 (7.6)
5 (33.3)
11.3 (2.6)
11 (73.3)
111.4 (37.5)
2.56 (0.2)
10 (66.7)
5 (33.3)

71.6 (10.6)
15 (55.6)
12.6 (3.7)
7 (25.9)
111.7 (46.5)
2.90 (0.3)
11 (40.7)
16 (59.3)

72.5 (7.4)
42 (46.7)
12.1 (2.8)
56 (62.2)
126.1 (33.6)
2.52 (0.3)
34 (37.8)
56 (62.2)

APOE, Apolipoprotein E; HV, hippocampal volume; MCI, mild cognitive impairment; LP, limbic predominant; MTL-sparing, mesial temporal
lobe sparing. ∗ APOE genotype was available for 17/19 tau negative, 13/15 LP, 23/27 MTL-sparing, and 69/90 Typical subgroup participants.
p < 0.05, MTL-sparing versus LP; p < 0.05 MTL-sparing versus Typical. † p < 0.001, tau negative versus LP; p < 0.001 tau negative versus
MTL-sparing; p < 0.001 tau negative versus Typical. ‡ HV was available for 18/19 tau negative, 12/15 LP, 21/27 MTL-sparing, and 84/90
Typical participants. p = 0.02, MTL-sparing versus LP; p < 0.001, MTL-sparing versus AD.

groups had significantly lower composite memory
scores than the tau negative group (Fig. 3B). The
Typical group also had significantly lower composite memory scores than the MTL-sparing group
(Fig. 3B). The MTL-sparing group had significantly
lower composite non-memory scores than the tau
negative and LP groups (Fig. 3C).
Tau 18 F-MK6240 voxel-wise analysis
Figure 4A shows voxel-wise relative differences
in tau 18 F-MK6240 SUVR images between the LP,
MTL-sparing, and Typical groups, relative to the

tau negative group. The LP group had greater tracer
retention in the MTL than the tau negative group. The
MTL-sparing and Typical groups had greater tracer
retention in cortical regions, including the posterior
cingulate, precuneus, inferior temporal, lateral temporal, lateral parietal, lateral occipital, orbitofrontal,
and prefrontal cortices than the tau negative group.
While both the MTL-sparing and Typical subgroups
had greater tracer retention in MTL regions than the
tau negative group, the effect was greater for the Typical group.
Figure 4B shows voxel-wise relative differences
in tau 18 F-MK6240 SUVR images between the LP,
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Fig. 3. Visually classified groups and cognition. Cognitive scores for the visually classified groups (tau negative, limbic predominant [LP],
mesial temporal lobe sparing [MTL-sparing], and Typical) as measured by the A) MMSE (where lower scores reflect a greater degree of
impairment); B) composite memory score (z-score); and C) composite non-memory score (z-score). ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001.

Fig. 4. Voxel-wise comparisons between visually classified groups. Voxel-wise contrasts between visually classified groups overlaid on a T1
MRI template with a threshold of significance of p < 0.001 (uncorrected for multiple comparisons). T-, tau negative; LP, limbic predominant;
MTLsp, mesial temporal lobe sparing.

MTL-sparing and Typical groups. The LP subtype
had greater tracer retention in the MTL than the MTLsparing group (Supplementary Figure 3); however,
this was not significant at a threshold of p < 0.001
(uncorrected). The MTL-sparing and Typical groups
both had higher cortical tau tracer retention than
the LP group. While the MTL-sparing and Typical
groups both had high cortical tau, the Typical group
had significantly higher tracer retention in the MTL
(Supplementary Figure 4). The LP group did not have

higher tracer retention in any areas compared to the
Typical group (data not shown).
Tau 18 F-MK6240 region-of-interest analysis
Tracer retention was quantified in three composite
ROI (Me, Te, and R) for the visually classified groups.
The tau negative group had low SUVR in all composite ROI (Supplementary Figure 5). The LP group had
elevated Me SUVR, but low cortical SUVR (Te and
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R). The MTL-sparing and Typical groups had similar
levels of cortical SUVR. However, the MTL-sparing
group had lower Me SUVR than the Typical group.

DISCUSSION
Heterogeneity in the distribution of tau has been
linked with differences in the clinical presentation of
AD. In clinical settings, visual rating of PET scans
is standard practice. In this study, tau 18 F-MK6240
PET scans of 151 A␤ positive participants with MCI
and dementia were visually classified into four categories: tau negative, LP, MTL-sparing, and Typical.
Robust intra- and inter-rater reliability was observed
(0.89 and 0.86, respectively). Consensus visual reads
resulted in the majority being classified as Typical
(60%), 10% LP, and 18% MTL-sparing. Voxel-wise
contrasts showed the areas of significant difference
across these groups. There were no significant differences between these groups in age or sex. The
tau negative group had significantly lower A␤ burden
(measured in Centiloids) than all other groups. The
MTL-sparing group had significantly lower APOE 4
carriage and relatively preserved hippocampal volumes compared to the LP and Typical groups. The
tau negative and LP groups had a higher proportion
of participants with MCI than dementia, while the
MTL-sparing and Typical groups had a greater proportion of participants with dementia than MCI. The
LP and Typical groups were observed to have the
most impaired composite memory scores. The MTLsparing group performed better on memory tasks than
the LP and Typical groups but had worse MMSE and
composite non-memory scores (which was significantly different when compared to the LP group).
Tau tracer 18 F-MK6240 has characteristics favoring its use for the reliable visual inspection of tau
in mesial temporal regions. Tracer retention in the
MTL adopted a “hook”-like distribution on sagittal
slices of tau PET images in the LP and Typical groups
due to tracer binding in the parahippocampal gyrus,
amygdala and anterior hippocampus (Fig. 1, Supplementary Figure 2). In contrast, the MTL-sparing
group had either absent tracer retention in this distribution, or visually much lower intensity binding
in this “hook”-like distribution in comparison to
the degree of cortical binding. Voxel-wise contrasts
showed that the LP group had higher MTL tracer
retention than the MTL-sparing group (Supplementary Figure 3), which was not significant at a threshold
of p < 0.001 (uncorrected). Additionally, while the

MTL-sparing and Typical groups both had high cortical 18 F-MK6240 tracer retention, the Typical group
had higher tracer retention in the MTL. Region-ofinterest analysis performed to quantify 18 F-MK6240
tracer retention in the MTL and cortex for the visually
classified groups also shows consistent findings (Supplementary Figure 5). These findings suggest that
while there is some MTL tau in the MTL-sparing
subtype, the MTL region appears spared, relative to
the high cortical tracer retention visualized.
While participants in this study were all A␤ ‘positive’ (Centiloid >25), the tau negative group had
a significantly lower burden of A␤ than the other
groups. As we have reported recently, a moderate
burden of A␤ may be necessary for tau to spread
into the cortex [22]. The tau negative group may also
comprise individuals with cerebral A␤ plaques and
comorbid pathology, such as TDP-43, which we cannot account for, but may be contributing toward their
clinical presentation sufficiently to warrant a clinical
classification of MCI or dementia. The visually classified Typical group in this study had tracer retention
in the MTL and cortex, as is observed in late Braak
stages [5]. Postmortem analyses in individuals with
AD (Braak stage V-VI) have identified LP and HpSp
subtypes, classified based on the relative burden of
hippocampal and cortical tau NFT observed [7, 8].
Lower NFT counts were observed in the hippocampus in the HpSp subtype, relative to the cortex [7]. The
HpSp subtype has been associated with younger age
of onset [7, 23], while the LP subtype has been associated with an older age of onset [7]. The HpSp subtype
has been associated with relatively preserved hippocampal volumes [7], similar to the MTL-sparing
group in this study. Studies that have identified analogous subtypes based on their MRI atrophy patterns
found that the HpSp subtype was associated with
lower APOE 4 carriage [24, 25], as in this study.
However, while The LP and HpSp-sparing subtypes
were identified in individuals with Braak stage V–VI
on postmortem evaluation, participants classified into
LP and MTL-sparing groups in this study did not
have this requirement. Participants who may have
the HpSp subtype, and atypical AD variants, would
fall into the visually classified MTL-sparing group in
this study. Thus, these differences limit direct comparison to the subtypes observed at postmortem. A␤
burden has been shown to be reasonable reflection
of disease duration [26]. The LP group did not differ significantly from the MTL-sparing and Typical
groups in terms of A␤ burden, yet did not have tau
in the cortex, beyond the inferior temporal lobe. This
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group may represent an earlier disease phase, based
on the distribution of their tau pathology, supported
by the higher frequency of participants with MCI
than dementia. Longitudinal analysis would yield further insights into the spatiotemporal trajectory of tau
accumulation in this group, and would be crucial in
determining whether the tau negative and LP groups
are distinct entities, or an earlier phase of AD.
The regional distribution of tau has been linked
with the development of neurodegeneration and the
clinical manifestations of AD [1–4]. The visually
classified groups with high MTL tau (LP and Typical) had the most impaired performance on memory
tests, while the visually classified groups with high
cortical tau (MTL-sparing and Typical) had the most
impaired performance on measures of non-memory
cognitive domains. Greater variation in the distribution of 18 F-MK6240 tracer retention was observed
in the Typical group than the MTL-sparing group.
Thus, differences in performance on composite nonmemory scores between these two groups should be
interpreted in this context.
The visual identification of 18 F-MK6240 PET
patterns could benefit clinical practice and clinical
trials. An AD diagnosis may be under-recognized in
individuals with a younger onset, predominant nonamnestic phenotype. These distribution patterns may
also be contributing to the variance in cross-sectional
and longitudinal studies, where the method to evaluate tau assumes the spatiotemporal distribution of tau
is stereotyped. This may also impact the participant
selection for clinical trials or results interpretation
where 18 F-MK6240 PET is used as an outcome measure. For example, an A␤+ individual with MCI may
have focal cortical tracer retention and may temporally be at an early stage of AD but could be
considered to have an advanced Braak stage (V–VI).
This participant may be excluded from a clinical trial
that defines disease severity by Braak staging (corresponding to the participant’s 18 F-MK6240 retention
pattern), even though they may be early in the AD
disease process.
The results in this study should be interpreted in
the context of some important limitations. The sample
size of this study was modest. The visual classification method was derived on the same sample as was
used for the main analysis, as an independent validation dataset was not available. While strong intra- and
inter-rater reliability was achieved, the visual classification was only performed by two readers. The
tau negative group may comprise a few participants
with very low levels of tau confined to the rhinal
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or entorhinal cortex. Insufficient clinical characterization of atypical AD variants in this cohort limits
more detailed evaluation of the relationship between
the tau PET distribution pattern and cognition. Future
studies should consider that the findings reported in
this study would be strengthened by a larger sample size, validation in an independent dataset, having
a larger number of readers perform visual reads,
and longitudinal analysis to explore how these tau
distribution patterns evolve over time. Post-mortem
data for 18 F-MK6240, and studies exploring genetic
and biological mechanisms could enhance our understanding of the potential reasons for these differences
in tau distribution patterns.
Conclusion
Tau distribution patterns, including a limbic pattern
and a mesial-temporal sparing pattern are visually
identifiable in vivo using tau tracer 18 F-MK6240.
Tracer retention in a “hook”-like distribution on sagittal sequences was observed in the LP and Typical
groups. The visually classified MTL-sparing group
had lower APOE 4 carriage and relatively preserved
hippocampal volumes compared to the LP and Typical groups. High MTL tau was associated with greater
amnestic cognitive impairment. High cortical tau was
associated with greater impairments on non-memory
domains of cognition, and individuals with high cortical tau were more likely to have dementia than MCI.
The visual identification of 18 F-MK6240 distribution patterns in vivo may benefit clinical practice and
clinical trials.
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